Liposuction of Breast Cancer-Related Arm Lymphedema Reduces Fat and Muscle Hypertrophy.

Adipose tissue deposition is a known consequence of lymphedema. A previous study showed that the affected arm in patients with nonpitting breast cancer-related lymphedema (BCRL) had a mean excess volume of 73% fat and 47% muscle. This condition impairs combined physiotherapy as well as more advanced microsurgical methods.

Breast cancer-related chronic arm lymphedema is associated with excess adipose and muscle tissue.

Background: Arm lymphedema is a common complication after breast cancer treatment. Although conservative treatment can be used to reduce swelling, treatment often fails, possibly due to chronic edema being transformed from lymph fluid to subcutaneous fat, a condition called nonpitting lymphedema. It is currently unknown if the excess volume is solely due to excess in fat.

Adipose tissue dominates chronic arm lymphedema following breast cancer: an analysis using volume rendered CT images.

Background: Arm lymphedema is a common complication after breast cancer treatment. Various types of conservative and surgical treatments have aimed at reducing the arm swelling, but most of these have failed due to chronic edema eventually being transformed from an accumulation of lymph fluid to an increased deposition of subcutaneous fat (i.e.

Tissue tonometry before and after liposuction of arm lymphedema following breast cancer.

Background: Arm lymphedema is a common complication after breast cancer treatment. Different conservative and surgical treatments have been used to reduce the arm swelling, but most have failed as chronic edema eventually transforms from a state of accumulated lymph fluid into increased deposition of subcutaneous fat, i.e.